Bilastine D6
| Product Name | Bilastine D6 |
|---|---|
| Alternate Names | Bilastine Stable Isotopes, Stable Isotopes of Bilastine |
| CAT No. | CS-O-15080 |
| CAS No. | 202189-78-4 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 469.65 g/mol |
| Mol. For. | C₂₈H₃₁D₆N₃O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bilastine |
| Purity | 95% |
| Therapeutic | Antihistamine |
| Smileys | CCOCCN1C(C2CCN(CCC3=CC=C(C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C(O)=O)C=C3)CC2)=NC4=CC=CC=C14 |
| Canonical Smiles | CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O |
| InchIKey | ACCMWZWAEFYUGZ-UHFFFAOYSA-N |
| Inchl | InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33) |
| IUPAC | 2-[4-[2-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]ethyl]phenyl]-2-methylpropanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Bilastine D6 is a deuterated form of bilastine, which is a second-generation H1-receptor antagonist used for the treatment of allergic rhinitis and urticaria. Bilastine D6 is a stable isotope-labeled version of bilastine, which is commonly used in pharmacokinetic studies to evaluate the metabolism, distribution, and elimination of bilastine in the body.
Chemically, bilastine D6 has the same molecular formula as bilastine, which is C28H37N3O3S. The only difference is that six hydrogen atoms in bilastine are replaced with deuterium atoms in bilastine D6. Deuterium is a non-radioactive isotope of hydrogen that has a higher atomic mass, which makes it useful for studying drug metabolism and pharmacokinetics.
Bilastine D6 is typically administered orally in tablet form. It is rapidly absorbed in the gastrointestinal tract and reaches peak plasma concentrations within 1-1.5 hours after ingestion. Bilastine D6 undergoes extensive metabolism in the liver, primarily via cytochrome P450 enzymes, and is eliminated from the body mainly through urine and feces.
In conclusion, Bilastine D6 is a helpful tool for researchers and clinicians to gain a better understanding of the pharmacokinetics and metabolism of bilastine, which can ultimately improve the treatment of allergic rhinitis and urticaria.
Get an Instant Quote
Related Compounds
Bilastine D4 |